A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LVSI / lymphovascular space invasion

[Related PubMed/MEDLINE]
Total Number of Papers: 280
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LVSI  (>> Co-occurring Abbreviation)
Long Form:   lymphovascular space invasion
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A novel prediction method for lymph node involvement in endometrial cancer: machine learning. CGSI, EC, LNI, MI, PaLNI
2019 A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. EC, FNR, LAD, NPV, SLN
2019 Comparison of oncologic outcomes of unanticipated cervical carcinoma in women undergoing inadvertent simple hysterectomy and those undergoing surgical treatment after preoperative diagnosis. ---
2019 Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer. ---
2019 Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. OS, PFS, PNI
2019 Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma. EC, ER, LN, PR
2019 Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma. AUC, CSCC, DCE, DWI, FS, LN, ROC
2019 Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus. CI, EC, HR, LNs, OS, PFS
2019 Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study. CCC, CI, HR, MI, UPSC
10  2019 The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population. LNM, NACT, NECC, RT
11  2019 [Application and clinical significance of Silva pattern system in invasive endocervical adenocarcinoma]. LN, PNI
12  2018 A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer. AA, DSS, EC, NAA, OS, RFS
13  2018 Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. ER, L1CAM, PR
14  2018 Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation. ---
15  2018 Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis. BMVD, LNM, MI, OS, SMD
16  2018 Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma. CSCC, HSIL, LSIL, SCCA
17  2018 Contemporary salvage post prostatectomy radiotherapy: Early implementation improves biochemical control. ADT, BCF, GS, IMRT, iPSA, SRT
18  2018 Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. age, race, CIs, EC, HRs, ILTCs, ORs, RFS
19  2018 Distribution of human papillomavirus genotypes and its relationship to clinicopathology in invasive cervical carcinoma in Zhejiang Province, China. DSI, HPV, ICC, LNM, SCC
20  2018 Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation. CI, HR
21  2018 ESGO Survey on Current Practice in the Management of Cervical Cancer. ---
22  2018 Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer. MI, TFD
23  2018 Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer. ---
24  2018 Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. CI, OR
25  2018 Intrauterine Manipulator Use During Minimally Invasive Hysterectomy and Risk of Lymphovascular Space Invasion in Endometrial Cancer. IUM, TAH, TLH
26  2018 Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. ---
27  2018 Isolated pulmonary metastases in patients with cervical cancer and the factors affecting survival after recurrence. FIGO, IPM, MCV, UCC
28  2018 L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion. L1CAM, MELF, MMR
29  2018 Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients. EC, IHC, LHCG-R
30  2018 MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively. CE, CI, ROC
31  2018 Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy. PNI
32  2018 Pathologic Staging of Endometrial Carcinomas: Selected Areas of Difficulty. AJCC, FIGO, UICC
33  2018 Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer. ADC, ESGO, ESMO, ESTRO, FIGO, MRI
34  2018 Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer. CI, EC, HR, MMI, OS, PFS
35  2018 Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer. ---
36  2018 Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer. MC, MPV, NLR, OS, PLR
37  2018 Retrospective analysis of surgery for cervical stump carcinoma at early stage. ---
38  2018 Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus. EC, LN, MMI
39  2018 Risk Factors for Recurrence in Low-Risk Endometrial Cancer: A Case-Control Study. CI, EC, OR, PTD
40  2018 Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis. LNM, PI
41  2018 Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study. CI, FIGO, LN
42  2018 Serum DNA integrity index as a potential molecular biomarker in endometrial cancer. BMI, cfDNA, EC, qPCR
43  2018 Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma. CI, HR, UCS
44  2018 Surgical and oncological outcomes of an improved nerve-sparing radical hysterectomy technique: 6 years of experience at two centres. DFS, FIGO, LCR, NSRH, OS, PVR
45  2018 Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens. AUC, FIGO, GTV, LNM, MRI
46  2018 [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. BMI, OS, PFS, SEOC
47  2018 [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy]. DSI, FIGO, NACT
48  2017 Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers. CRT, LRC, MVA, OR, OS, RT
49  2017 Comparison of Survival Outcomes in Early Stage Invasive Adenocarcinoma with Squamous Cell Carcinoma of the Uterine Cervix. AC, CSI, OS, RFS, SCC
50  2017 Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer. CI, HR
51  2017 Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification-A Preliminary Analysis. DMI, MR
52  2017 Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. BMI, CI, DSS, EC, ER, HR, IHC, L1CAM, OS, POLE, PR, ProMisE, PTEN, WT
53  2017 Evaluation of unusual and highly aggressive variant of endometrium cancer: nonendometrioid endometrium carcinoma of the uterus. DFS, LNM, LRC, OS, RT
54  2017 Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. USC
55  2017 HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer. CC
56  2017 Incidence of Lymph Node Metastasis in Surgically Staged FIGO IA G1/G2 Endometrial Cancer With a Tumor Size of More Than 2 cm. EC
57  2017 Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion. ---
58  2017 Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer. AACCI, DSS, EC, OS, RFS
59  2017 Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis. DSS, EC, OS
60  2017 Is parametrectomy always necessary in early-stage cervical cancer? PI
61  2017 L1CAM: amending the "low-risk" category in endometrial carcinoma. ---
62  2017 Lymphovascular Space Invasion for Endometrial Cancer: Undertreatment and Overtreatment Risks. ---
63  2017 Lymphovascular Space Invasion for Endometrial Cancer: Undertreatment and Overtreatment Risks: A Survey of the Spanish Gynecologic Oncology Group. ---
64  2017 Microcystic, elongated, and fragmented pattern of invasion in relation to histopathologic and clinical prognostic factors in endometrioid endometrial adenocarcinoma. EEA, MELF
65  2017 Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment. LNM
66  2017 Parametrial involvement in women with low-risk, early-stage cervical cancer. DSI
67  2017 Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion. CEA, EC, FIGO, Fn, ROC, WBC
68  2017 Risk factors for paraaortic lymph node metastasis in endometrial cancer. CI, EC, LN, OR
69  2017 Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2cm warrant lymph node dissection? EEC, MELF
70  2017 [Study on the relationship between laparoscopic operation and pseudo vascular invasion in stage Ⅰa endometrial carcinoma]. PVI
71  2017 [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy]. DFS, DM, LRR, NAC, OS, PMRT
72  2016 Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma. OR, OS, PFS, UPSC
73  2016 Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer. ---
74  2016 Development and validation of a surgical-pathologic staging and scoring system for cervical cancer. DFS, FIGO, LNM, OS, SPSs
75  2016 Evaluation of the association between perineural invasion and clinical and histopathological features of cervical cancer. PNI
76  2016 Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion. COX-2, IHC
77  2016 Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma. Cdc42, PAK1
78  2016 Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer. ---
79  2016 Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo. HCC, KLF6
80  2016 Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. HCC, lncRNAs
81  2016 Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer. DM, LABC, LRR, OS, pCR, RFS, RT
82  2016 Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? OS, RFS
83  2016 Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. ---
84  2016 Management of Isolated Vaginal Metastasis in Squamous Cell Cervical Cancer: 23 Years' Experience at a Single Center. CC, CRT, CT, DOI, IVM, RT
85  2016 Nestin: A biomarker of aggressive uterine cancers. IHC, PFS, UCs
86  2016 Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study. AC, ASC, CSS, DSI, PI, PLN, RFS, TGOG
87  2016 Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group. CI, DFS, OS, UCSs
88  2016 Prognostic significance of HPV status in postoperative squamous-cell carcinoma of the head and neck. DFS, ECE, HNSCC, HPV, LRC, OS, PNI
89  2016 Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions. EAOC, OCCC, OS, RFS
90  2016 Risk Factors for Parametrial Involvement in Early-Stage Cervical Cancer and Identification of Patients Suitable for Less Radical Surgery. DSI, PI
91  2016 Risk of Parametrial Spread in Small Stage I Cervical Carcinoma: Pathology Review of 223 Cases With a Tumor Diameter of 20 mm or Less. ---
92  2016 Significance of the Factors Associated With Parametrial Involvement in Stage IB to IIA Cervical Cancer. PI
93  2016 Stage-III and -IV endometrial cancer: A single oncology centre review of 104 cases. EC, OR, OS, PFS
94  2016 Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases. OR, OS, PFS, SEOCs
95  2016 The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study. DFS, NACT, OS
96  2016 [Diagnosis and treatment value of colposcopy and loop electrosurgical excision procedure in microinvasive cervical cancer: analysis of 135 cases]. CDB, LEEP, MCC
97  2015 Assessment of primary radical hysterectomy and neoadjuvant chemotherapy followed by radical hysterectomy in Stage IB2, IIA bulky cervical cancer. DFS, OS
98  2015 Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy? RP
99  2015 Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers. CCC, CHREC, CS, ESC, HR
100  2015 CD14+ macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead? TDLN